Weight Loss
-
GLP-1s Extend Beyond Weight Loss to Treat Heart Disease and Addiction
New research suggests GLP-1 drugs may help with heart disease, sleep apnea, and addiction, expanding their role beyond diabetes and obesity.
-
How Chronic Stress and the Hormone Cortisol Can Push Appetite and Weight Up
Gurugram, June 19 — The number on the scale keeps climbing. The diet looks clean. The workout routine is consistent. Yet for…
-
Stress, Sleep, Hormones: Why You Gain Weight Despite Not Overeating
Gurugram, June 19 — For many people, the struggle to lose weight or maintain a healthy weight is a constant battle, despite…
-
Mazdutide Meets All Key Goals in Chinese Phase III Obesity Trial, Innovent Says
China, May 21, 2025 — infopulsetoday.com — New clinical data released in May 2025 show that the investigational drug mazdutide, a once-weekly…
-
Diabetes Drugs Show Promise in Treating Addiction and Cravings
A class of medications originally developed for diabetes is now being investigated for a completely different purpose: treating addiction. GLP-1 receptor agonists,…
-
Pfizer Drug Ponsegromab Boosts Weight in Cachexia Trial
Cancer patients losing dangerous amounts of weight have long had few medical options. A monoclonal antibody called ponsegromab might change that. Pfizer…
-
FDA Approves Lilly’s Mounjaro, a Once-Weekly Dual-Action Drug for Type 2 Diabetes
Millions of Americans who live with type 2 diabetes now have an additional medication to consider. Tir tirzepatide, cleared by the U.S.…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Bacteria Pair Cleared Tumours in Mice in 2025 Study; Not Yet Tested in People
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
GLP-1s Extend Beyond Weight Loss to Treat Heart Disease and Addiction
-
Sacituzumab Tirumotecan Boosts Survival in Advanced Gastroesophageal Cancer
-
FDA approves Novo Nordisk’s Sogroya as first weekly growth hormone for Turner syndrome
-
Blood Biomarker eMTBR-tau243 Detects Advanced CTE in Living Patients
-
Cemdisiran Cuts Dosing to Four Shots a Year in Myasthenia Gravis
-
How to Pay Down Credit Card Debt Before Holiday Spending Peaks
-
Small Business Sale Can Trigger Up to 37% Federal Tax, New Data Shows
-
Annuity Renewal Traps: How Automatic Rollovers Lock Retirees Into Lower Rates
-
How Fed Cuts, Bank Competition and Deposit Insurance Could Crash High-Yield Savings Rates
-
How 401(k) Holders Can Automatically Cut Single-Stock Concentration Risk
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992







